Bioscience ReportsCancer BiologyPeer-reviewed journal article
Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1 and 2 in HCT116 colorectal cancer cells
Laiyen García DelgadoiD, Amélie Derome, Samantha Longpré, Marilyne Giroux-Dansereau, Ghenwa Basbous, Christine L. LavoieiD, Caroline SaucieriD, Jean‐Bernard DenaultiD
Abstract
Cumulative research findings support the idea that endocytic trafficking is crucial in regulating receptor signaling and associated diseases. Specifically, strong evidence points to the involvement of sorting nexins (SNXs), particularly SNX1 and SNX2, in the signaling and trafficking of the receptor tyrosine kinase (RTK) MET in colorectal cancer (CRC). Activation of hepatocyte growth factor (HGF) receptor MET is a key driver of CRC progression. In this study, we utilized human HCT116 CRC cells with SNX1 and SNX2 genes knocked out to demonstrate that their absence leads to a delay in MET entering early endosomes. This delay results in increased phosphorylation of both MET and AKT upon HGF stimulation, while ERK1/2 (extracellular signal-regulated kinases 1 and 2) phosphorylation remains unaffected. Despite these changes, HGF-induced cell proliferation, scattering, and migration remain similar between the parental and the SNX1/2 knockout cells. However, in the absence of SNX1 and SNX2, these cells exhibit increased resistance to TRAIL-induced apoptosis. This research underscores the intricate relationship between intracellular trafficking, receptor signaling, and cellular responses and demonstrates for the first time that the modulation of MET trafficking by SNX1 and SNX2 is critical for receptor signaling that may exacerbate the disease.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 2
- FWCI
- 0.29
- Field percentile
- 42th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SNX2, but not SNX1, regulates the hepatocyte growth factor receptor MET in HCT116 colorectal cancer cells
Laiyen García Delgado, Amélie Derome, … Jean‐Bernard Denault·bioRxiv·Oct 7, 2026
- CRISPR/Cas9 screenings reveal the role of STX1A and CDK1 in Cathepsin G entering and killing colorectal cancer cells
Yuxiang Wang, Valery Rozen, … Zhenghe Wang·Interdisciplinary Information SciencesPeer-reviewed·Jan 1, 2025
- Epidermal Growth Factor/c-Met receptor signalling crosstalk drives tunneling nanotube formation in A549 lung adenocarcinoma cells
Salonee Banerjee, Aya Elmeligy, … Anastasia Sobolewski·bioRxiv·Jan 26, 2026
- FCHSD2 Controls Oncogenic ERK1/2 Signaling Outcome by Regulating Endocytic Trafficking
S. L. Schmid, G.-Y. Xiao·bioRxiv·Jan 29, 2020
- Colorectal adenocarcinomas downregulate the mitochondrial Na+/Ca2+ exchanger NCLX to drive metastatic spread
T. Pathak, M. Gueguinou, … M. Trebak·bioRxiv·May 7, 2020
- RAB14-dependent tubulovesicular recycling directs MET to invadopodia promoting TNBC cell invasion
Amrita Khamari, Atreyee Guria, … Sunando Datta·bioRxiv·Sep 23, 2025